• Markets
  • icon
  • Companies
EMD · ASX

Emyria Ltd (ASX:EMD)

AU$0.061

 0.002 (3.39%)
ASX:Live
12/04/2024 03:32:38 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

EMD Overview

EMD Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About EMD

Website

Emyria Ltd

Telephone

Address

Description

Emyria Ltd. is a healthcare technology and services company. It operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from informed and consenting patients. The company was founded on March 19, 2018 and is headquartered in Leederville, Australia.

EMD Price Chart

Key Stats

Market Cap

AU$21.63M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.04 - 0.18

Trade Value (12mth)

AU$9,139.00

1 week

-1.61%

1 month

-8.96%

YTD

10.91%

1 year

-62.76%

All time high

0.501287

Key Fundamentals

EPS 3 yr Growth

-41.800%

EBITDA Margin

-421.80%

Operating Cashflow

-$4m

Free Cash Flow Return

-55.40%

ROIC

-75.40%

Interest Coverage

-52.20

Quick Ratio

0.90

Other Data

Shares on Issue (Fully Dilluted)

333m

HALO Sector

Next Company Report Date

27-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EMD Announcements

Latest Announcements

Date Announcements

10 April 24

Emyria Opens Empax Centre to Advance Mental Health Care

×

Emyria Opens Empax Centre to Advance Mental Health Care

05 April 24

Emyria Expands Specialist AP Team - First Female for MDMA-AT

×

Emyria Expands Specialist AP Team - First Female for MDMA-AT

03 April 24

Emyria, Reach Wellness Enter MDMA-AT Research Agreement

×

Emyria, Reach Wellness Enter MDMA-AT Research Agreement

19 March 24

Notification of cessation of securities - EMD

×

Notification of cessation of securities - EMD

12 March 24

Response to ASX Aware Query

×

Response to ASX Aware Query

08 March 24

Response to ASX Price Query

×

Response to ASX Price Query

29 February 24

Emyria Half Year Results FY2024

×

Emyria Half Year Results FY2024

28 February 24

Appendix 4D and Half Year End Financial Report

×

Appendix 4D and Half Year End Financial Report

23 February 24

Notification of cessation of securities - EMD

×

Notification of cessation of securities - EMD

02 February 24

Webinar Presentation

×

Webinar Presentation

31 January 24

December 2023 Quarterly Activities Report and Appendix 4C

×

December 2023 Quarterly Activities Report and Appendix 4C

30 January 24

Notification of cessation of securities - EMD

×

Notification of cessation of securities - EMD

15 January 24

Emyria Receives $2.5M R&D Tax Incentive Refund

×

Emyria Receives $2.5M R&D Tax Incentive Refund

10 January 24

Emyria Specialist Granted Authorised Prescriber Status

×

Emyria Specialist Granted Authorised Prescriber Status

10 January 24

Company Overview and Strategic Update

×

Company Overview and Strategic Update

02 January 24

Change of Director's Interest Notice - M. Winlo

×

Change of Director's Interest Notice - M. Winlo

27 November 23

Notification of cessation of securities - EMD

×

Notification of cessation of securities - EMD

27 November 23

Change in Substantial Holding

×

Change in Substantial Holding

22 November 23

Final Director's Interest Notice - S. Washer

×

Final Director's Interest Notice - S. Washer

22 November 23

Initial Director's Interest Notice - G. Hutchinson

×

Initial Director's Interest Notice - G. Hutchinson

21 November 23

Application for quotation of securities - EMD

×

Application for quotation of securities - EMD

21 November 23

Eminent Healthcare Leader New Independent Non-Exec Chair

×

Eminent Healthcare Leader New Independent Non-Exec Chair

16 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

13 November 23

Board Changes and Executive Restructuring

×

Board Changes and Executive Restructuring

13 November 23

Final Director's Interest Notice - A. Vickery

×

Final Director's Interest Notice - A. Vickery

EMD Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.03 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.03 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 26.3 -22.8 35.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.02 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.02 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 38.5 -28.8 32.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -9.8 -10.8 -10.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.02 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.01 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.3 -50.9 -96.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 219 267 289 Lock Lock Lock
Basic m Lock Lock Lock Lock 219 267 289 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 2 2 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 95.0 -7.8 -12.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 4 4 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -4 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 43.1 -178.6 24.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -80.2 -242.2 -208.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 180 342 309 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -5 -8 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.3 -51.9 17.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -271.6 -447.1 -421.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -6 -9 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1.4 -49.5 16.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -289.0 -468.5 -447.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -5 -8 -7 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -1 -2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -5 -7 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.3 -49.4 30.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -248.3 -402.1 -322.2 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -4 -5 -4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 2 3 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -2 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 7 5 6 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 -5 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.2 -38.9 30.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.0 -3.0 -2.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 4 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 9 8 10 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -6 -3 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 2 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 7 6 7 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 8 7 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 98.6 -15.7 3.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -54.2 -88.8 -50.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -68.3 -115.9 -75.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -91.2 -113.2 -94.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -82.3 -100.3 -75.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -66.0 -74.3 -55.4 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -80.3 -112.8 -52.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.0 0.4 0.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -77.7 -51.4 -21.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.7 2.8 0.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.7 2.8 0.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 94.8 94.3 95.8 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -381.4 -373.0 -119.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 10.0 10.1 18.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.3 0.7 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 12.4 34.0 70.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -248.3 -465.9 -453.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -54.2 -102.9 -71.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -54.2 -88.8 -50.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.3 1.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -68.3 -115.9 -75.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -68.3 -115.9 -75.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 36.5 36.1 19.8 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 36.5 36.1 19.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 20.2 25.3 64.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 16.3 10.8 -44.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EMD Shortsell

Frequently Asked Questions

The current share price of Emyria Ltd (EMD:ASX) is AU$0.061.
The 52-week high share price for Emyria Ltd (EMD:ASX) is AU$0.18.
The 52-week low share price for Emyria Ltd (EMD:ASX)? is AU$0.04.
Emyria Ltd (EMD:ASX) does not pay a dividend.
Emyria Ltd (EMD:ASX) does not pay a dividend.
Emyria Ltd (EMD:ASX) has a franking level of 0%.
Emyria Ltd (EMD:ASX) is classified in the Technology.
The current P/E ratio for Emyria Ltd (EMD:ASX) is .